Rankings
▼
Calendar
PRGO FY 2023 Earnings — Perrigo Company plc Revenue & Financial Results | Market Cap Arena
PRGO
Perrigo Company plc
$1B
FY 2023 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$4.7B
+4.6% YoY
Gross Profit
$1.7B
36.1% margin
Operating Income
$152M
3.3% margin
Net Income
-$13M
-0.3% margin
EPS (Diluted)
$-0.09
Cash Flow
Operating Cash Flow
$406M
Free Cash Flow
$304M
Stock-Based Comp.
$69M
Balance Sheet
Total Assets
$10.8B
Total Liabilities
$6.0B
Stockholders' Equity
$4.8B
Cash & Equivalents
$751M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$4.7B
$4.5B
+4.6%
Gross Profit
$1.7B
$1.5B
+15.5%
Operating Income
$152M
$79M
+92.5%
Net Income
-$13M
-$141M
+91.0%
← Q4 2022
All Quarters
Q1 2023 →